Virtual Screening for Potential Inhibitors of High-Risk Human Papillomavirus 16 E6 Protein

Interdisciplinary Sciences – Computational Life Sciences

Volumn 7, Issue 2, 2015, Pages 136-142

  Kumar, Satish ^a   Jena, Lingaraja ^a   Mohod, Kanchan ^a   Daf, Sangeeta ^b   Varma, Ashok K ^c  

^a MAHATMA GANDHI INSTITUTE OF MEDICAL SCIENCES   (India)

^b DATTA MEGHE INSTITUTE OF MEDICAL SCIENCES   (India)

^c CANCER RESEARCH INSTITUTE   (India)

Author keywords

Cancer; E6; HPV 16; Inhibitors; p53; Virtual screening

Indexed keywords

ANTINEOPLASTIC AGENT; ANTIVIRUS AGENT; E6 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 16; LIGAND; ONCOPROTEIN; REPRESSOR PROTEIN;

ANTAGONISTS AND INHIBITORS; CHEMICAL STRUCTURE; CHEMISTRY; COMPUTER AIDED DESIGN; DRUG DESIGN; DRUG EFFECT; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; METABOLISM; MOLECULAR DOCKING; PAPILLOMAVIRUS INFECTION; PROTEIN CONFORMATION; STRUCTURE ACTIVITY RELATION; VIROLOGY;

ANTINEOPLASTIC AGENTS; ANTIVIRAL AGENTS; COMPUTER-AIDED DESIGN; DRUG DESIGN; HUMAN PAPILLOMAVIRUS 16; HUMANS; LIGANDS; MOLECULAR DOCKING SIMULATION; MOLECULAR STRUCTURE; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRUS INFECTIONS; PROTEIN CONFORMATION; REPRESSOR PROTEINS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84940539618     PISSN: 19132751     EISSN: 18671462     Source Type: Journal    
DOI: 10.1007/s12539-015-0008-z     Document Type: Article

References (22)

1. de Martel C, Ferlay J, Franceschi S, Vignat J, Bray F, Forman D, Plummer M (2012) Global burden of cancers attributable to infections in 2008: a review and synthetic analysis. Lancet Oncol 13:607–615
2. Hoory T, Monie A, Gravitt P, Wu TC (2008) Molecular epidemiology of human papillomavirus. J Formos Med Assoc 107:198–217
3. Parkin DM, Bray F (2006) Chapter 2: the burden of HPV-related cancers. Vaccine 3124:11–25
4. Guan P, Howell-Jones R, Li N, Bruni L, de Sanjosé S, Franceschi S, Clifford GM (2012) Human papillomavirus types in 115, 789 HPV-positive women: a meta-analysis from cervical infection to cancer. Int J Cancer 131:2349–2359
5. Chaturvedi AK (2010) Beyond cervical cancer: burden of other HPV-related cancers among men and women. J Adolesc Health 46:20–26
6. Scheffner M, Munger K, Byrne JC, Howley PM (1991) The state of the p53 and retinoblastoma genes in human cervical carcinoma cell lines. Proc Nat Acad Sci USA 88:5523–5527
7. Hubbert NL, Sedman SA, Schiller JT (1992) Human papillomavirus type 16 E6 increases the degradation rate of p53 in human keratinocytes. J Virol 66:6237–6241
8. Talis AL, Huibregtse JM, Howley PM (1998) The role of E6AP in the regulation of p53 protein levels in human papillomavirus (HPV)-positive and HPV-negative cells. J Biol Chem 73:6439–6445
9. Lee HG, Yu KA, Oh WK, Baeg TW, Oh HC, Ahn JS, Jang WC, Kim JW, Lim JS, Choe YK, Yoon DY (2005) Inhibitory effect of jaceosidin isolated from Artemisia argyi on the function of E6 and E7 oncoproteins of HPV 16. J Ethnopharmacol 98:339–343
10. Wolf LK (2009) New software and websites for the chemical enterprise. Chem Eng News 87:31
11. Kelley LA, Sternberg MJ (2009) Protein structure prediction on the Web: a case study using the Phyre server. Nat Protoc 4:363–371
12. Krieger E, Joo K, Lee J, Lee J, Raman S, Thompson J, Tyka M, Baker D, Karplus K (2009) Improving physical realism, stereochemistry, and side-chain accuracy in homology modeling: four approaches that performed well in CASP8. Proteins 77:114–122
13. Laskowski RA, MacArthur MW, Moss DS, Thornton JM (1993) PROCHECK: a program to check the stereochemical quality of protein structures. J Appl Crystallogr 26:283–291
14. Wiederstein M, Sippl MJ (2007) ProSA-web: interactive web service for the recognition of errors in three-dimensional structures of proteins. Nucleic Acids Res 35:407–410
15. Wallner B, Elofsson A (2003) Can correct protein models be identified? Protein Sci 12:1073–1086
16. Eisenberg D, Lüthy R, Bowie JU (1997) VERIFY3D: assessment of protein models with three-dimensional profiles. Methods Enzymol 277:396–404
17. Colovos C, Yeates TO (1993) Verification of protein structures: patterns of non bonded atomic interactions. Protein Sci 2:1511–1519
18. Irwin JJ, Shoichet BK (2005) ZINC-a free database of commercially available compounds for virtual screening. J Chem Inf Model 45:177–182
19. Trott O, Olson AJ (2010) AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem 31:455–461
20. Zanier K, Charbonnier S, Sidi AO, McEwen AG, Ferrario MG, Poussin-Courmontagne P, Cura V, Brimer N, Babah KO, Ansari T, Muller I, Stote RH, Cavarelli J, Vande Pol S, Travé G (2013) Structural basis for hijacking of cellular LxxLL motifs by papillomavirus E6 oncoproteins. Science 339:694–698
21. Crook T, Tidy JA, Vousden KH (1991) Degradation of p53 can be targeted by HPV E6 sequences distinct from those required for p53 binding and trans-activation. Cell 67:547–556
22. Oprea TI (2002) Virtual screening in lead discovery: a viewpoint. Molecules 7:51–62